title: Significance of serum butyrylcholinesterase levels in oral cancer.
abstract: BACKGROUND
  Oral squamous cell carcinoma (OSCC) is a relatively common epithelial malignancy, and thus represents a significant public health problem. Early detection improves quality of life for affected patients. Identification of molecular markers (or biomarkers) which can predict disease progression is necessary for better management of these disorders. A correlation of cholinesterase with tumourigenesis, cell proliferation and cell differentiation has been observed. Butyrylcholinesterase (BChE; pseudocholinesterase) has been shown to be a biochemical marker for cervical cancer which is also an epithelial malignancy. In this study, we sought to estimate and compare serum BChE levels in healthy controls and patients with biopsy-proven oral squamous cell cancer (also an epithelial malignancy) before definitive therapy as radiotherapy or chemotherapy may alter the levels of BChE and may act as a confounding variable.
  
  
  METHODS
  After obtaining consent from biopsy proven oral cancer patients (n= 39) (before onset of any definitive treatment), and from age- and sex-matched healthy controls (n = 20), 2ml of blood was collected. After clot formation samples were centrifuged, serum was collected for estimation of BChE.
  
  
  RESULTS
  Pre-treatment serum BChE levels were significantly elevated (p < 0.0001) in oral cancer patients compared to that of controls. BChE levels showed a significant increase (p = 0.005) with advancing stage in oral cancer patients.
  
  
  CONCLUSIONS
  Our results show there could be a role for serum BChE in determining the prognosis of oral cancer.
authors: Department of Biochemistry Kasturba Medical College, Manipal, Manipal University, India.
authors: K
authors: K
authors: Prabhu
authors: D
authors: D
authors: Naik
authors: S
authors: S
authors: Ray
authors: Vadiraj
authors: A
authors: A
authors: Rao
authors: A
authors: A
authors: Kamath
keywords: Butyrylcholinesterase; oral carcinoma; prognosis
references: J Cancer Res Ther. 2008 Jan-Mar;4(1):21-5
references: 18417898
references: Oral Oncol. 2010 Sep;46(9):644-7
references: 20656542
references: Mutat Res. 2008 Feb 1;638(1-2):184-94
references: 18035380
references: Coll Antropol. 2000 Dec;24(2):373-80
references: 11216405
references: Recent Results Cancer Res. 1998;154:47-85
references: 10026993
references: Neurochem Int. 1996 May-Jun;28(5-6):453-83
references: 8792327
references: Anticancer Res. 2003 Jan-Feb;23(1B):605-12
references: 12680155
references: J Oral Pathol Med. 2009 Nov;38(10):737-52
references: 19903246
references: Clin Exp Metastasis. 2008;25(7):787-98
references: 18612832
references: Community Dent Oral Epidemiol. 2005 Dec;33(6):397-9
references: 16262606
references: Biochem J. 1989 Jun 15;260(3):625-34
references: 2669736
references: J Cancer Res Ther. 2007 Jul-Sep;3(3):167-8
references: 18079581
references: J Oral Pathol Med. 1992 Mar;21(3):109-12
references: 1349918
references: Ann Oncol. 1997 Apr;8(4):343-50
references: 9209663
references: Int J Clin Oncol. 2007 Jun;12(3):231-3
references: 17566849
references: Clin Chim Acta. 1995 Jun 15;237(1-2):91-105
references: 7664482
references: Cancer Cells. 1991 Dec;3(12):511-6
references: 1820094
references: J Clin Invest. 1990 Sep;86(3):900-8
references: 2394839